Navigation
Skip to Content
Study on the transposition measures of Member States in relation to the pharmaceutical legislation (Art. 118a of Directive 2001/83/EC)
DisplayLogo
Publications Office of the European Union
MainSearch
All collections
EU law
EU publications
EU official directory
Editorial Content
Summaries of Legislation
search
More
Advanced search
Browse by subject
Expert Search
Language Selector
български (bg)
español (es)
čeština (cs)
dansk (da)
Deutsch (de)
eesti keel (et)
eλληνικά (el)
English (en)
français (fr)
Gaeilge (ga)
hrvatski (hr)
italiano (it)
latviešu valoda (lv)
lietuvių kalba (lt)
magyar (hu)
Malti (mt)
Nederlands (nl)
polski (pl)
português (pt)
română (ro)
slovenčina (sk)
slovenščina (sl)
suomi (fi)
svenska (sv)
BasketSummary
0
MyPortal
Sign in
Navigation Menu
LAW
EU PUBLICATIONS
RESEARCH AND INNOVATION
OPEN DATA
PUBLIC PROCUREMENT
EU WHOISWHO
Navigation Menu
LAW
EU PUBLICATIONS
RESEARCH AND INNOVATION
OPEN DATA
PUBLIC PROCUREMENT
EU WHOISWHO
Publications Office of the EU
Help
Navigation Menu
Breadcrumb
Publication detail
Navigation Menu
AccessibilityTools
Maintenance EN
Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
Web Content Display (Global)
For a better user experience please update your browser or use
Chrome
or
Firefox
browser.
×
custom-survey-notification
We would like to hear your views on this publication.
Please provide your feedback
Publication Detail Actions Portlet
Utilities
Add to my publications
Create alert
Permanent link
Metadata RDF
(Opens New Window)
(Opens New Window)
Embed in website
Rate this publication
Publication Detail Portlet
Study on the transposition measures of Member States in relation to the pharmaceutical legislation (Art. 118a of Directive 2001/83/EC)
Final report
EU publications
Publication metadata
In 2011, to address the threat of falsified medicines, Directive 2011/62/EU amended Directive 2001/83/EC to include measures aimed at preventing the entry of falsified medicinal products into the legal supply chain. Article 118a of the Directive includes the requirement for Member States (MS) to introduce penalties related to the falsification of medicinal products, active substances and
View more
excipients. This report outlines the measures in place or taken by Member States to transpose, implement and enforce Article 118a of the Directive and gathers and assesses relevant information regarding the effectiveness of those measures. It includes: The penalties in place in each Member State ; A Member States overview with respect to these measures ; An assessment of the effectiveness of the measures ; Recommendations on improving the achievement of the objectives of Article 118a. The study gives an overview of the situation in the EU in mid-2017 and should feed into the Commission Report to be sent to the European Parliament and Council in January 2018. In any case, Member States should have notified the European Commission of the national provisions adopted by January 2013.
View less
Download and languages
Available languages and formats
Available languages and formats
bg
es
cs
da
de
et
el
en
pdf
fr
ga
hr
it
lv
lt
hu
mt
nl
pl
pt
ro
sk
sl
fi
sv
Publication details
Related publications
Published:
2018-01-16
Corporate author(s):
Directorate-General for Health and Food Safety
(
European Commission
)
,
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH
,
ZEIS Centre for European and International Studies in Criminal Law
Personal author(s):
Möller, Uriel
;
Maly, Simon
;
Rennoch, Jonas
;
Berg, Michael
;
Sinn, Arndt
;
Stroetmann, Karl
Themes:
Pharmaceutical and cosmetics industry
,
Approximation of legislation
Subject:
administrative sanction
,
application of EU law
,
approximation of laws
,
data collection
,
EU Member State
,
illicit trade
,
industrial counterfeiting
,
national implementing measure
,
penalty
,
pharmaceutical industry
,
pharmaceutical legislation
,
pharmaceutical product
,
public health
ISSN
ISBN
DOI
Catalogue number
PDF
978-92-79-73869-2
10.2875/41105
EW-04-17-864-EN-N
View more
View less
Publication Viewer
Document viewer
The document doesn't have a viewable format at this time
Go Back Widget
Back to list of results
&WT.cellarId=a1201026-fb39-11e7-b8f5-01aa75ed71a1&WT.w_doc_catalogue_number=EW-04-17-864-EN-N&WT.publicationLanguage=en&WT.publicationDetailDisplayed=1&WT.keywords=administrative sanction;application of EU law;approximation of laws;data collection;EU Member State;illicit trade;industrial counterfeiting;national implementing measure;penalty;pharmaceutical industry;pharmaceutical legislation;pharmaceutical product;public health&WT.publicationAuthor=SANTE, agent.empirica Gesellschaft für Kommunikations- und Technologieforschung mbH, agent.ZEIS Centre for European and International Studies in Criminal Law&WT.publicationFormat=PDF&WT.publicationCollection=EUPub&){kind=small}